a double-blind crossover study of the efficacy of disodium cromoglycate given by mouth to control the cutaneous , gastrointestinal and central-nervous-system manifestations of systemic mastocytosis was carried out in five patients for periods of eight to 32 months .
C0012694
disodium cromoglycate
C0024899
mastocytosis